YTENQ has been in the news 900% more than usual

YTENQ has been in the news recently: YIELD10 Bioscience is not directly involved in the studies presented by Factor Bioscience Inc. at the ASGCT Annual Meeting, which focus on allogeneic CAR-T therapies. Additionally, Nordic Bioscience's PRO-C3 test, now available on Roche Diagnostics' cobas analysers, assesses liver fibrosis severity, which is associated with a significant number of global deaths.